Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Pediatr.

Sec. Pediatric Cardiology

Volume 13 - 2025 | doi: 10.3389/fped.2025.1678095

Combination of CRP and MiRNA Signature as a Potential Diagnostic Strategy for Kawasaki Disease

Provisionally accepted
Xiaoyan  HuangXiaoyan Huang1Huiting  LiHuiting Li1Xiangrong  ZhaoXiangrong Zhao1Haixiang  ZhangHaixiang Zhang1Yaping  LiYaping Li1Qian  NiuQian Niu1Jiaojiao  WangJiaojiao Wang2Cuixiang  XuCuixiang Xu1*
  • 1Shaanxi Provincial People's Hospital, Xi'an, China
  • 2Yan'an University, Yan'an, China

The final, formatted version of the article will be published soon.

Background: Kawasaki disease is the leading cause of acquired heart disease in children, yet timely diagnosis remains difficult due to overlapping symptoms with other febrile illnesses. Methods: In a retrospective case–control study of 38 children with Kawasaki disease and 44 febrile controls, we measured hematological parameters and C-reactive protein (CRP) using standardized analyzers and profiled seven serum microRNAs by qRT-PCR. Biomarkers showing significant differences were used to build logistic regression models with a 70/30 train–test split, and diagnostic accuracy was assessed by receiver operating characteristic analysis. Functional enrichment of miRNA targets was explored using network analysis. Results: CRP and three microRNAs (miR-223-3p, miR-19a-3p, miR-18a-5p) were significantly elevated in Kawasaki disease. Individually, these markers achieved strong discrimination (AUC 0.846– 0.986), while their combination yielded an AUC of 0.990, sensitivity 1.000, and specificity 0.923. The three microRNAs were positively correlated and enriched for pathways including p53 signaling and cell cycle regulation, with KCNQ1OT1 identified as a shared lncRNA interactor. Conclusion: Integrating CRP with a concise serum miRNA panel demonstrates promising discriminatory potential for Kawasaki disease versus other febrile illnesses and suggests mechanistic involvement of p53-associated pathways, supporting future validation in larger, independent cohorts.

Keywords: kawasaki disease, biomarker, C-Reactive Protein, microRNA, Diagnostic strategy

Received: 01 Aug 2025; Accepted: 26 Sep 2025.

Copyright: © 2025 Huang, Li, Zhao, Zhang, Li, Niu, Wang and Xu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Cuixiang Xu, xucuixiang@spph-sx.ac.cn

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.